Redeye initiates coverage of VEF, a specialised investment company that offers rare public market access to high-growth private fintech firms in emerging markets, including Brazil, Mexico, and India. With a proven NAV IRR of 12% since inception, a maturing portfolio (90% break-even) featuring gems like Creditas and Juspay, and a 45% NAV discount, Redeye argues investors are overlooking VEF’s underlying value and improved industry dynamics.

Read more and download the Research Report.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/